|
| Press Releases |
|
 |
|
| Friday, April 3, 2020 |
|
|
아방스 클리니컬, APAC 바이오테크 고객사들이 임상시험을 위해 호주를 선택하는 주요 이유 밝혀 |
| 호주의 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 클라이언트 온보딩 피드백을 토대로 APAC 바이오테크 기업들이 초기 임상시험을 위해 호주를 선택하는 주요 이유를 오늘 밝혔다. more info >> |
|
| Thursday, April 2, 2020 |
|
|
Avance Clinical on Top Reasons APAC Biotech Clients Choose Australia for Clinical Trials |
| Leading Australian CRO Avance Clinical today detailed the top reasons its APAC biotechs selected Australia for their early phase clinical trials, based on client onboarding feedback. more info >> |
|
| Friday, March 20, 2020 |
|
|
澳大利亞CRO, Avance Clinical公司在COVID-19疫苗和臨床試驗治療方案方面具有得天獨厚的優勢 |
| 澳大利亞CRO Avance Clinical今天表示，澳大利亞快速的監管審批環境，關鍵意見領袖的專業知識和高質量的臨床研究中心，以及頗具吸引力的40%的政府臨床試驗支出退稅，所有這一切都意味著Avance具有得天獨厚的優勢，能夠使緊迫的COVID-19試驗速見成效。 more info >> |
|
|
澳大利亚CRO, Avance Clinical公司在COVID-19疫苗和临床试验治疗方案方面具有得天独厚的优势 |
| 澳大利亚CRO Avance Clinical今天表示，澳大利亚快速的监管审批环境，关键意见领袖的专业知识和高质量的临床研究中心，以及颇具吸引力的40%的政府临床试验支出退税，所有这一切都意味着Avance具有得天独厚的优势，能够使紧迫的COVID-19试验速见成效。 more info >> |
|
|
호주 임상시험수탁기관인 아방스 클리니컬, COVID-19 백신 및 치료제 개발을 위한 임상시험에 독보적 위치 점유 |
| 호주의 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 호주의 빠른 규제 승인 환경과 주요 오피니언 리더들의 전문성, 고품질 임상 연구소 및 임상시험 지출에 대해 정부가 지급하는 40%의 보조금 등으로 인해 자신들이 COVID-19 관련 임상시험에서 신속히 결과를 낼 수 있는 유리한 위치에 있다고 오늘 밝혔다. more info >> |
|
|
Australian CRO, Avance Clinical is Uniquely Positioned for COVID-19 Vaccines and Therapies Clinical Trials |
| Australian CRO Avance Clinical said today that Australia's fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites, as well as the attractive 40% Government rebate on clinical trial spend, means Avance is uniquely positioned to deliver rapid results for urgent COVID-19 trials. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million
Jun 12, 2025 21:07 HKT/SGT
|
|
|
健倍苗苗二零二五財年全年業績表現亮眼 純利飆升51.2%至1.97億港元
Jun 12, 2025 20:58 HKT/SGT
|
|
|
健倍苗苗二零二五财年全年业绩表现亮眼 纯利飙升51.2%至1.97亿港元
Jun 12, 2025 20:48 HKT/SGT
|
|
|
品質基石的守護者：檢測檢驗行業賦能高質量發展
Jun 12, 2025 18:28 HKT/SGT
|
|
|
质量基石的守护者：检测检验行业赋能高质量发展
Jun 12, 2025 18:19 HKT/SGT
|
|
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 16:38 HKT/SGT
|
|
|
耐賦康(R)與EVER001協同發力 雲頂新耀推動腎病治療進入精準管理新階段
Jun 12, 2025 16:31 HKT/SGT
|
|
|
耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段
Jun 12, 2025 16:26 HKT/SGT
|
|
|
10 winners selected at 8th edition of Start-up Express
Jun 12, 2025 12:29 HKT/SGT
|
|
|
LEGENDARY HUMANITY Announces Strategic Bitcoin Reserves and Enhancements to the VIVI Token Ecosystem
Jun 12, 2025 09:00: JST
|
|
|
LEGENDARY HUMANITY Announces Strategic Bitcoin Reserves and Enhancements to the VIVI Token Ecosystem
Jun 12, 2025 08:00 HKT/SGT
|
|
|
This Technology is Conquering the World: Neutrinovoltaics Redefining Global Infrastructure
Jun 11, 2025 21:00 HKT/SGT
|
|
|
這項技術正在征服世界：中微子光電技術正在重新定義全球基礎設施
Jun 11, 2025 21:00 HKT/SGT
|
|
|
这项技术正在征服世界：中微子光伏技术正在重新定义全球基础设施
Jun 11, 2025 21:00 HKT/SGT
|
|
|
HKTDC Design Gallery x STICKYLINE present: "Love HK" Exhibition
Jun 11, 2025 13:34 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
